Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions. [electronic resource]
Producer: 19891114Description: 939-45 p. digitalISSN:- 0026-0495
- Adult
- Aged
- Apolipoprotein A-I
- Apolipoproteins A -- metabolism
- Apolipoproteins B -- metabolism
- Cholesterol -- metabolism
- Cholesterol, HDL -- metabolism
- Cholesterol, LDL -- metabolism
- Drug Evaluation
- Female
- Gemfibrozil -- administration & dosage
- Humans
- Hyperlipidemias -- prevention & control
- Lipid Metabolism
- Lipoprotein Lipase -- metabolism
- Lipoproteins, HDL -- metabolism
- Liver -- enzymology
- Male
- Middle Aged
- Peritoneal Dialysis, Continuous Ambulatory -- adverse effects
- Time Factors
- Triglycerides -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.